newest glp 1 The next generation of GLP-1 weight loss drugs and chromium in a daily dosage of 2 capsules FDA approves Foundayo, an oral

A well-executed deep plane facelift releases the four retaining ligaments and repositions tissue without tension, which produces less swelling and bruising than the older skin-tightening technique

Carney JA, Hruska LS, Beauchamp GD & Gordon H

Based on announcements in early 2026, the FDA and HHS signaled reclassifying a group of peptides, including BPC-157, TB-500, and injectable GHK-Cu, toward Category 1, which makes them eligible for use by licensed compounding pharmacies preparing individualized medications under a prescription

The complex biotechnological manufacturing of peptide-based therapies, which requires sophisticated facilities and lengthy production timelines, makes rapid scaling a logistical challenge